You have 9 free searches left this month | for more free features.

Condition

Osteosarcoma (3)

Overall Status

Terminated (2)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Millennium Pharmaceuticals, Inc. (1)

UNICANCER (1)

University of Oxford (1)

Collaborator

European Commission (1)

Millennium: The Takeda Oncology Company (1)

National Institute for Health Research, United Kingdom (1)

Oxford University Hospitals NHS Trust (1)

Intervention

mifamurtide (3)

ei or m-api regimen depending on patient age (1)

ifosfamide (1)

Study Documents

Intervention Type

drug (3)

combination product (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational (1)

mifamurtide

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Osteosarcoma Trial in France (Mifamurtide, EI or M-API regimen depending on patient age)

Recruiting

Osteosarcoma

Mifamurtide
EI or M-API regimen depending on patient age

Amiens, France
+30 more

Dec 8, 2022

Osteosarcoma Trial in Worldwide (Mifamurtide, Ifosfamide)

Terminated

Has Results

Osteosarcoma

Mifamurtide
Ifosfamide

Münster, Germany
+7 more

Aug 7, 2019

Surveillance Study of Patients With Newly Diagnosed Osteosarcoma

Terminated

Osteosarcoma

Mifamurtide

Wien, Austria

AKH Wien Universitätsklinik für Innere Medizin I Klinische Abtei

Jan 17, 2017